[{"id":"d248a372-e196-4938-a786-16c5881ac2c6","acronym":"","url":"https://clinicaltrials.gov/study/NCT02201420","created_at":"2021-04-20T07:52:25.888Z","updated_at":"2024-07-02T16:37:28.845Z","phase":"Phase 2","brief_title":"Evaluation of Tc 99m Tilmanocept Localization in Primary Cutaneous Kaposi's Sarcoma and Lymphatic Drainage by SPECT/CT","source_id_and_acronym":"NCT02201420","lead_sponsor":"Navidea Biopharmaceuticals","biomarkers":" MRC1","pipe":" | ","alterations":" MRC1 expression","tags":["MRC1"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e MRC1 expression"],"overall_status":"Completed","enrollment":" Enrollment 5","initiation":"Initiation: 09/01/2014","start_date":" 09/01/2014","primary_txt":" Primary completion: 03/01/2015","primary_completion_date":" 03/01/2015","study_txt":" Completion: 10/01/2015","study_completion_date":" 10/01/2015","last_update_posted":"2016-09-27"}]